Pharma Stories, Blogs, Interviews & Press Releases
Special Import and Emergency Tenders: How Suppliers Can Bid Without a Local Registration
By the PharmaTradz BD Team. Published November 2026. Most pharmaceutical tenders have one condition that rules out the m...
Read Full Story
Reserve Antibiotics: How Hospitals and Distributors Can Source Last-Line Treatments
By the PharmaTradz BD Team. Published November 2026. When a patient has an infection caused by bacteria resistant to car...
Read Full Story
US Drug Discontinuations: What the FDA List Means for Manufacturers and Exporters
By the PharmaTradz BD Team. Published November 2026. Most attention goes to the US drug shortage list. The FDA's list of...
Read Full Story
WHO Opens Prequalification for Childhood Cancer and Opioid Medicines: What Manufacturers Should Know
By the PharmaTradz BD Team. Published October 2026. In the space of four months, WHO has opened its prequalification pro...
Read Full Story
The EU Pharma Package and Generic Launches: What Changes for Generic and Biosimilar Companies
By the PharmaTradz BD Team. Published October 2026. Europe's medicines law is about to change for the first time in more...
Read Full Story
US Tariffs on Generic Medicines from 2028: What Buyers and Exporters Should Plan for Now
By the PharmaTradz BD Team. Published October 2026. In July, the US President announced on social media that imported ge...
Read Full Story
How to Choose a CDMO in Europe: EU-GMP Licences, QP Release and What to Check (2026)
By the PharmaTradz BD Team. Published October 2026. People searching for a contract manufacturer in Europe often type th...
Read Full Story
US Pharma Tariffs Three Weeks In: What API and Finished-Dose Buyers Need to Know
By the PharmaTradz BD Team. Published October 2026. The US tariff on patented medicines has now applied to every importe...
Read Full Story
The Netherlands Moves to Restrict Ashwagandha: What Supplement Exporters Should Do Now
By the PharmaTradz BD Team. Published October 2026. Ashwagandha is one of the best-selling botanicals of the decade. It...
Read Full Story
October's New US Drug Shortages: Where Licensed Suppliers Can Step In
By the PharmaTradz BD Team. Published October 2026. Every few weeks, a new set of medicines goes on the US shortage list...
Read Full Story
Nitrosamines After CPHI Milan 2026: What Buyers Should Ask For in a Dossier
By the PharmaTradz BD Team. Published October 2026. Nitrosamines have been on regulators' lists since 2018, and the form...
Read Full Story
FDA's Proposed Mandatory GRAS Rule: What Ingredient Suppliers Should Do Now
By the PharmaTradz BD Team. Published October 2026. On 11 August 2026, the US Food and Drug Administration proposed maki...
Read Full Story